FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT

Core Viewpoint - FOXO Technologies Inc. has announced a 1 for 10 reverse stock split of its Class A common stock to comply with NYSE American listing requirements, effective April 28, 2025 [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders at the Annual Meeting on November 29, 2024, with a ratio ranging from 1 for 5 to 1 for 100 [2]. - Every ten shares of Common Stock will be combined into one share, with no change in the par value of $0.0001 per share [2]. - Fractional shares will be rounded up to the next whole number for stockholders [2]. Group 2: Compliance and Impact - The reverse stock split aims to ensure compliance with NYSE American's requirement for a stock price above$0.10 [3]. - The company does not anticipate any impact on its current or future business operations due to the reverse stock split [3]. Group 3: Adjustments and Procedures - All outstanding stock options, warrants, and equity incentive plans will be proportionately adjusted according to their terms [4]. - Continental Stock Transfer & Trust Company will act as the exchange agent for the reverse stock split, providing instructions for stockholders regarding the exchange process [5]. Group 4: Company Overview - FOXO Technologies Inc. operates three subsidiaries: Rennova Community Health, Inc., Myrtle Recovery Centers, Inc., and Foxo Labs, Inc., focusing on healthcare and biotechnology [6][7].